Azenta, Inc. (AZTA) vs Immunome, Inc. (IMNM)
A side-by-side comparison of Azenta, Inc. and Immunome, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AZTA
Azenta, Inc.
$43.94HealthcareDelayed quote: Oct 6, 2026, 10:10 AM EDT
IMNM
Immunome, Inc.
$20.69HealthcareDelayed quote: Oct 6, 2026, 10:10 AM EDT
Total return — AZTA vs IMNM
growth of $100 · dividends reinvested · last 6yAZTA -2.9% (-0.5%/yr)IMNM +57.4% (+7.9%/yr)IMNM compounded faster over this window
AZTA IMNM
AZTA vs IMNM: by the numbers
- •AZTA is the larger company ($2.03B vs $1.98B market cap).
- •Both run net losses; AZTA's is the smaller (-20.02% vs -3059.99% net margin).
Metrics side by side
Valuation
| Metric | AZTA | IMNM |
|---|---|---|
| Forward P/E | 88.47 | N/A |
| P/S ratio | 3.30 | N/A |
| P/B ratio | 1.34 | 3.77 |
| EV / EBITDA | 55.19 | N/A |
| FCF yield | 0.49% | N/A |
Profitability
| Metric | AZTA | IMNM |
|---|---|---|
| Gross margin | 44.05% | 57.43% |
| Operating margin | -3.49% | -3084.76% |
| Net margin | -20.02% | -3059.99% |
| ROE | -8.14% | -48.43% |
| ROIC | -1.33% | -51.06% |
Growth (annualized)
| Metric | AZTA | IMNM |
|---|---|---|
| Revenue CAGR (5Y) | 4.82% | N/A |
| Total return CAGR (5Y) | -15.91% | 2.88% |
Frequently asked
- How have AZTA and IMNM total returns compared?
- Over the past 5 years, AZTA delivered -15.91% and IMNM delivered 2.88% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.